Market Tracker

12/09 5:16pm ET

Merck & Co Inc (NYSE:MRK)

61.23
Delayed Data
As of 4:00pm ET
 +1.11 / +1.85%
Today’s Change
47.97
Today|||52-Week Range
65.46
+15.92%
Year-to-Date
US Market Indexes End the Week Higher
4:57pm / GuruFocus News - Paid Partner Content
J&J (JNJ) Stands Tall in 2016: Reasons for Outperformance
Nov 30 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: MasterCard, Merck, Cisco and Visa
Dec 08 / Zacks.com - Paid Partner Content
Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab
Nov 30 / Zacks.com - Paid Partner Content
Top Research Reports for Cisco, Merck & MasterCard
Dec 07 / Zacks.com - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content
Why AstraZeneca plc Stock Slumped in November
Dec 07 / MotleyFool.com - Paid Partner Content
Merck: Keytruda's Priority Review for New Cancer Indication
Nov 29 / Zacks.com - Paid Partner Content
Lilly: Jardiance Label to Add Cardiovascular Indication
Dec 06 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALI...
Nov 28 / Zacks.com - Paid Partner Content
Intermediate Trade: Merck
Dec 06 / TheStreet.com - Paid Partner Content
J&J (JNJ) Confirms it Approached Actelion for Possible Deal
Nov 28 / Zacks.com - Paid Partner Content
Kite Pharma Begins Filing for KTE-C19, Presents Data at ASH
Dec 05 / Zacks.com - Paid Partner Content
Novo Nordisk: shot in the dark
Nov 25 / FT.com - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
AstraZeneca given green light to resume cancer drug trials
Nov 22 / FT.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
Stunning! Dow hits new high of 19,000 as Trump rally continues
Nov 22 / CNNMoney.com
Alexandria Real Estate, Merck Ink Long-Term Pharma Lease
Dec 01 / Zacks.com - Paid Partner Content
The Trump market rally: Too far, too fast
Nov 14 / CNNMoney.com
5 Top Performing S&P 500 Stocks of November
Dec 01 / Zacks.com - Paid Partner Content
Clinton defeat provides antidote to US drugmakers
Nov 10 / FT.com - Paid Partner Content
Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study
Dec 01 / Zacks.com - Paid Partner Content
Wall Street rallies led by healthcare and banks
Nov 09 / FT.com - Paid Partner Content
3 Ways Organovo Holdings, Inc. Plans to Grow Exponentially for Years to Come
Dec 01 / MotleyFool.com - Paid Partner Content
Drug and biotech stocks soar on Trump victory
Nov 09 / CNNMoney.com
Quest to cure Alzheimer's disease exhibits symptoms of failure
Nov 30 / FT.com - Paid Partner Content